logo
Medical news
of the North Caucasus
Scientific journal
Mass media registration certificate dated December 7, 2006.
Series ПИ #ФС 77-26521.
Federal service for surveillance over non-violation of the legislation in the sphere of mass communications and protection of cultural heritage.
ISSN 2073-8137
rus
русский
eng
english

Site search



Correspondence address
310 Mira Street, Stavropol, Russia, 355017

Tel
+7 865 2352511, +7 865 2353229.

E-mail
medvestnik@stgmu.ru

Efficiency of combined therapy of syndrome of the overlap between gastroesophageal reflux disease and functional dyspepsia

[Abstracts]
Irina Golub;

The effectiveness of treatment of patients with a syndrome of the overlap between gastroesophageal reflux disease and functional dyspepsia has been studied. Two groups of patients were formed: in the first group combination of prokinetic drug itoprid and proton pump inhibitor omeprazole was administered; in the second – only omeprazole.
After the course of treatment, a control study (24-hour electrogastrography and 24-hour pH-metry) was performed. The use of combination of itoprid and omeprazole significantly improved the condition of patients and parameters of myoelectric activity of the stomach, decreased the acid exposure of the esophagus.

Download

References:
1. Hershcovici T., Fass R. Curr. Opin. Gastroenterol. 2010;26:367-378.
2. Kim S. E., Park H. K., Kim N. J. Clin. Gastroenterol. 2014;48:12-18.
3. Noh Y. W., Jung H. K., Kim S. E., Jung S. A. Neurogastroenterol. 2010;16:148-156.
4. Sobieraj D. M., Coleman S. M., Coleman C. L. Am. J. Man. Care. 2011;17:449-458.
5. Suzuki H., Okada S., Hibi T. Ther Adv. Gastroenterol. 2011;4(4):219-226.

Keywords: gastroesophageal reflux disease, functional dyspepsia, overlap syndrome, myoelectric activity of stomach, itoprid, omeprazole


Founders:
Stavropol State Medical Academy
Pyatigorsk State Research Institute of Balneotherapeutics
Pyatigorsk State Pharmaceutical Academy